No insider purchase over the last 90 days. The latest, by 미래에셋자산운용, was filed 07 Jul 2026.
Who traded when
BuySale+4 other insiders
Since the insiders bought
- -23.0%Entry ₩122,000 · Close 30 Oct 2026 ₩94,000
- -39.7%Entry ₩156,000 · Close 30 Oct 2026 ₩94,000
- -39.7%Entry ₩156,000 · Close 30 Oct 2026 ₩94,000
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 22,909 sharesKRXDART:20260707000375Canonical exit: 5 Oct 2026 (T+90)
- 28,333 sharesKRXDART:20260601002020
- 1,000 shares@ ₩77,750.000.017% mcap100.0% of flowShareKRXDART:20260601001993
- 33,333 shares@ ₩149,578.000.21% mcap100.0% of flowShareKRXDART:20260601001983Canonical exit: 30 Aug 2026 (T+90)
- 3,000 shares@ ₩22,300.000.0029% mcap100.0% of flowShareKRXDART:20260601002002Canonical exit: 24 Aug 2026 (T+90)
- 51,023 sharesKRXDART:20260401002426Canonical exit: 28 Jun 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 3,000 sharesShareKRXDART:20260226005289Canonical exit: 27 May 2026 (T+90)
- 20,000 sharesShareKRXDART:20260226005530Canonical exit: 27 May 2026 (T+90)
- 2,000 sharesShareKRXDART:20260226005264Canonical exit: 27 May 2026 (T+90)
- 3,000 sharesShareKRXDART:20260226005508Canonical exit: 27 May 2026 (T+90)
- 80,700 sharesKRXDART:20251224000573
- 20,000 sharesShareKRXDART:20251224000576
- 37,500 sharesShareKRXDART:20251216000014
- 420,917 sharesKRXDART:20250311000381
- 458,317 sharesKRXDART:20250310000563
- 63,536 sharesKRXDART:20250203000393
- 1,392 sharesKRXDART:20241125000241
25 of 59 declarations
About OliX Pharmaceuticals, Inc
Sales dominate at OliX Pharmaceuticals, Inc (올릭스): 34 sales against 9 purchases, or 21% purchases, and no sale carries an amount. 이동기, filed as 대량보유자, made 32 of the 55 filings, with 2 purchases and 29 sales. The purchase of June 1, 2026, EUR 2.8 million, is the largest in the record and makes up most of the EUR 2.9 million of purchases with an amount; the other, EUR 38,133, is Kim Kelly Kyung Mi's (이사) on May 26, 2026.
박준현 (상무) made 8 filings, 1 of them a purchase, 미래에셋자산운용 made 2, with 1 purchase and 1 sale, and the company 4. On February 26, 2026, 4 filers bought on one day. Taking every period together, 2 purchase filings are tagged as clustered.
Read moreShow less
This South Korean health care company, valued at KRW 2.3 trillion, has 15.1% of its capital held by insiders, 11 filers. Published between February 16, 2021 and July 16, 2026, filings range from 3 in 2024 to 14 in 2023 and in 2026. Over the last 12 months there are 17 filings, 8 purchases and 4 sales. Taking the 19 filings with a known delay, publication follows the trade by a median of 6 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
